Skip to main content

Citigroup, Eli Lilly, Halliburton in the spotlight

U.S. stock futures pointed lower Monday as the shock waves from the Goldman Sachs fraud allegations continue, with results from Citigroup and Eli Lilly also in focus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.